
‘Gargantua' deep-sea creature among new species found in Atlantic. See them
Vents that connect underground rifts to the surface release billowing clouds of black deposits of iron sulfide, earning the moniker 'black smoker chimneys.'
These hydrothermal vent fields are hot, chemically rich and toxic to most forms of life. But, a special few organisms have adapted to call them their home.
Now, two new species found around the black smoker chimneys of the Hydra and Falkor hydrothermal vent fields have been identified — and they're huge.
Researchers operating the remote underwater vehicle SuBastian, from the Schmidt Ocean Institute, and the human-occupied vehicle Nautile, from the French Institute of Research and Exploitation of the Sea, used suctioning tools to collect peltospirid gastropods from the black smokers, according to a study published June 5 in the peer-reviewed Zoological Journal of the Linnean Society.
The peltospirid gastropods, or a family of marine snails found around hot vents, were compared to known species, but their 'very large' size immediately tipped off researchers that they may belong to new species.
Genetic testing confirmed their suspicions, according to the study.
The first new species, Peltospira gargantua, was found on a black smoker chimney in the Hydra field at a depth of about 12,300 feet, researchers said.
With a shell smaller than an inch, the snail is 'very large' compared to others in their genus, researchers said. The shell is 'rather tightly coiled,' and their bodies have 'short, paddle-like' tentacles.
Part of the shell is an 'olive green' color, but the shells are typically 'obscured by dark brown to reddish layers of' mineral deposits, according to the study.
'The head is large, with a thick and broad snout that expands slightly towards the mouth,' researchers said of the snail's body. The animals have no trace of eyes on their external bodies, not uncommon for creatures found in the dark abyss of the Atlantic.
Researchers named the species after Gargantua, a character from the French novels 'The Five Books of the Lives and Deeds of Gargantua and Pantagruel,' stories of a giant king and his son.
'The word Gargantua has since been used to mean 'huge' or 'immense,' as exemplified by the English adjective gargantuan,' according to the study. 'Thus, the species name refers to the very large size of the new species in relationship to other known (relatives).'
The second new species, from a different genus, was named after Gargantua's son, Pantagruel, according to the study.
Lirapex pantagruel is the 'largest of all known Lirapex species, hence the name of a giant is fitting,' researchers said.
The species was found on the black smokers of the Falkor hydrothermal vents at a depth of about 13,000 feet, according to the study.
This species is even smaller, with a shell diameter of about 0.3 inches long, and the shell is 'tightly coiled,' researchers said.
The pantagruel snail is also covered in reddish to blackish material, but has a semi-transparent and greenish hue otherwise.
'The soft parts are overall typical of the genus Lirapex,' researchers said. 'The head is large and without pigmented eyes… The snout is short, flattened, with the mouth opening ventrally. A pair of thin, film-like jaws are present.'
Finding the two new species was a 'surprising discovery,' researchers said, as the areas where they live have only been explored for a few years.
'Hydrothermal vents on the northern (Mid-Atlantic Ridge) have been explored for about four decades. Yet, species of large snails aggregating in conspicuous habitats near hot fluid orifices, such as P. gargantua and L. pantagurel, have remained undiscovered until now,' researchers said. 'It might be that the two new species are present only in Hydra and Falkor EMARK, two vent fields that were found only in 2023.'
The research team includes Chong Chen, Florence Pradillon, Coral Diaz-Recio Lorenzo and Joan Manel Alfaro-Lucas.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scientific American
3 days ago
- Scientific American
New Brain Device Is First to Read Out Inner Speech
After a brain stem stroke left him almost entirely paralyzed in the 1990s, French journalist Jean-Dominique Bauby wrote a book about his experiences—letter by letter, blinking his left eye in response to a helper who repeatedly recited the alphabet. Today people with similar conditions often have far more communication options. Some devices, for example, track eye movements or other small muscle twitches to let users select words from a screen. And on the cutting edge of this field, neuroscientists have more recently developed brain implants that can turn neural signals directly into whole words. These brain-computer interfaces (BCIs) largely require users to physically attempt to speak, however—and that can be a slow and tiring process. But now a new development in neural prosthetics changes that, allowing users to communicate by simply thinking what they want to say. The new system relies on much of the same technology as the more common 'attempted speech' devices. Both use sensors implanted in a part of the brain called the motor cortex, which sends motion commands to the vocal tract. The brain activation detected by these sensors is then fed into a machine-learning model to interpret which brain signals correspond to which sounds for an individual user. It then uses those data to predict which word the user is attempting to say. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. But the motor cortex doesn't only light up when we attempt to speak; it's also involved, to a lesser extent, in imagined speech. The researchers took advantage of this to develop their 'inner speech' decoding device and published the results on Thursday in Cell. The team studied three people with amyotrophic lateral sclerosis (ALS) and one with a brain stem stroke, all of whom had previously had the sensors implanted. Using this new 'inner speech' system, the participants needed only to think a sentence they wanted to say and it would appear on a screen in real time. While previous inner speech decoders were limited to only a handful of words, the new device allowed participants to draw from a dictionary of 125,000 words. 'As researchers, our goal is to find a system that is comfortable [for the user] and ideally reaches a naturalistic ability,' says lead author Erin Kunz, a postdoctoral researcher who is developing neural prostheses at Stanford University. Previous research found that 'physically attempting to speak was tiring and that there were inherent speed limitations with it, too,' she says. Attempted speech devices such as the one used in the study require users to inhale as if they are actually saying the words. But because of impaired breathing, many users need multiple breaths to complete a single word with that method. Attempting to speak can also produce distracting noises and facial expressions that users find undesirable. With the new technology, the study's participants could communicate at a comfortable conversational rate of about 120 to 150 words per minute, with no more effort than it took to think of what they wanted to say. Like most BCIs that translate brain activation into speech, the new technology only works if people are able to convert the general idea of what they want to say into a plan for how to say it. Alexander Huth, who researches BCIs at the University of California, Berkeley, and wasn't involved in the new study, explains that in typical speech, 'you start with an idea of what you want to say. That idea gets translated into a plan for how to move your [vocal] articulators. That plan gets sent to the actual muscles, and then they carry it out.' But in many cases, people with impaired speech aren't able to complete that first step. 'This technology only works in cases where the 'idea to plan' part is functional but the 'plan to movement' part is broken'—a collection of conditions called dysarthria—Huth says. According to Kunz, the four research participants are eager about the new technology. 'Largely, [there was] a lot of excitement about potentially being able to communicate fast again,' she says—adding that one participant was particularly thrilled by his newfound potential to interrupt a conversation—something he couldn't do with the slower pace of an attempted speech device. To ensure private thoughts remained private, the researchers implemented a code phrase: 'chitty chitty bang bang.' When internally spoken by participants, this would prompt the BCI to start or stop transcribing. Brain-reading implants inevitably raise concerns about mental privacy. For now, Huth isn't concerned about the technology being misused or developed recklessly, speaking to the integrity of the research groups involved in neural prosthetics research. 'I think they're doing great work; they're led by doctors; they're very patient-focused. A lot of what they do is really trying to solve problems for the patients,' he says, 'even when those problems aren't necessarily things that we might think of,' such as being able to interrupt a conversation or 'making a voice that sounds more like them.' For Kunz, this research is particularly close to home. 'My father actually had ALS and lost the ability to speak,' she says, adding that this is why she got into her field of research. 'I kind of became his own personal speech translator toward the end of his life since I was kind of the only one that could understand him. That's why I personally know the importance and the impact this sort of research can have.' The contribution and willingness of the research participants are crucial in studies like this, Kunz notes. 'The participants that we have are truly incredible individuals who volunteered to be in the study not necessarily to get a benefit to themselves but to help develop this technology for people with paralysis down the line. And I think that they deserve all the credit in the world for that.'


New York Post
5 days ago
- New York Post
Massive jellyfish swarm forces shutdown of major nuclear power plant
Four reactors at France's Gravelines nuclear power plant, located along the English Channel, were temporarily shut down over the weekend after a swarm of jellyfish threatened to clog critical water intake systems. According to the plant's operator, several of the facility's production units went offline after jellyfish were detected in the filter drums of the plant's pumping stations. Advertisement The French multinational electric utility company said the pumping stations, located in the non-nuclear section of the site, supply cooling water essential for the facility's operation. 'They had no impact on the safety of the facilities, the safety of personnel, or the environment,' EDF said in a statement. The Gravelines nuclear power plant is one of the largest nuclear facilities in Western Europe and has been connected to the grid since the 1980s. The impacts of jellyfish on coastal power plants is not without precedent, as there have been similar incidents reported around the globe during the summer months. Advertisement Along the English Channel, jellyfish sightings are frequent and can occasionally result in beach closures due to safety concerns for swimmers. Much of the North Sea and Mediterranean Sea have experienced above-average water temperatures this year, fueling extensive heat waves and creating more favorable conditions for jellyfish. Previous studies have suggested warmer seas can also accelerate jellyfish breeding cycles, increasing the likelihood of large swarms. The production units at the nuclear power plant went offline after jellyfish were seen in the filter drums of the pumping stations. AFP via Getty Images Advertisement In June, several French nuclear reactors reduced output to limit the amount of discharge into waterways because of record-breaking sea surface temperatures. The country's regulations require operators to avoid releasing waste, as overheated water can harm aquatic life. Warm water is known to place additional stress on marine species, lower oxygen levels and disrupt sensitive ecosystems. Jellyfish sightings are very common along the English Channel, which has led to beach closures across the area. AFP via Getty Images Advertisement Despite the recent interruptions at the Gravelines plant, France has not reported issues meeting the demand for electricity. According to the World Nuclear Association, the country generates about 70% of its electricity from nuclear energy and frequently exports surplus power to neighboring nations. EDF said plant teams remain mobilized and are conducting diagnostics and technical interventions to clear the intake systems and safely restart the affected units. The utility did not say when it expects to have the reactors back online to generate power for the grid.

Politico
5 days ago
- Politico
Bhattacharya and Kennedy split on mRNA cuts
AROUND THE AGENCIES National Institutes of Health Director Jay Bhattacharya is making the case that mRNA vaccine technology is 'promising, but not yet ready for prime time.' He cites a lack of public trust in the technology as the reason his boss, Health Secretary Robert F. Kennedy Jr.,recently canceled $500 million in mRNA vaccine development projects. Bhattacharya weighed in on Kennedy's decision in a conversation over the weekend with Steve Bannon, the longtime Trump ally and prominent MAGA figure, on Bannon's 'War Room' podcast: 'The reason that he did that — and I think it's very important for people to understand — as far as public health goes for vaccines, the mRNA platform is no longer viable,' Bhattacharya said. 'You can't have a platform where such a large fraction of the population distrusts the platform, if you're going to use it for vaccines, and expect it to work.' But, but, but: Kennedy, who has long been suspicious of the mRNA vaccine platform, offered an explanation for the funding cuts that contradicts Bhattacharya's reasoning. 'After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses,' Kennedy said in a video posted on social media last week, referring to Covid-19 and flu mRNA vaccines. Big picture: Scientists and drugmakers worry that Kennedy's skepticism of mRNA could stifle cancer treatment developments, our Lauren Gardner reports. mRNA technology can instruct the immune system to attack problem proteins, so it holds promise as a customized treatment for rare cancers and diseases. As such, dozens of mRNA therapies are being studied or are in the drug-development pipeline. Bhattacharya seemed aware of the technology's use beyond flu and Covid vaccines. After telling Bannon that mRNA technology wasn't ready for widespread vaccine use, he added: 'For cancer, maybe it's another story.' WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. A swarm of jellyfish shut down reactors at a French nuclear power station, Ketrin Jochecová, our POLITICO colleague in Europe, reports. Share any thoughts, news, tips and feedback with Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: RuthReader.02 or ErinSchumaker.01. OPERATING ROOM A large-scale study of New York's Mount Sinai Health System suggests that artificial intelligence could help emergency departments better handle their patient loads. In the study, researchers from Mount Sinai trained an AI model on 1.8 million emergency department visits between January 2019 and December 2023. Then they tested the model by comparing it with two months' worth of nurse triage assessments of nearly 50,000 patient visits across the system's urban and suburban hospitals. The result: Nurse predictions were 81.6 percent accurate, while the AI model's assessments were 85.4 percent accurate. The study, published in the journal Mayo Clinic Proceedings: Digital Health in July, had a few limitations, the authors noted, including that the research was conducted at a single health system over a short time span. Outcomes might differ in another setting, and longer-term trends could yield different results. Bird's eye view: 'The strength of this approach is its ability to turn complex data into timely, actionable insights for clinical teams — freeing them up to focus less on logistics and more on delivering the personal, compassionate care that only humans can provide,' Dr. Eyal Klang, study co-author and director of the Generative AI Research Program at Mount Sinai, said in a statement.